In summary, CIP treatment 1) significantly improved survival after CI; 2) partially ameliorated CI-induced severe anemia; 3) increased BMP4 production by F4/80+ macrophages in spleen; and 4) elevated IL-3 concentrations in serum of CI mice. The gene discussed is IL3; the disease is hereditary sensory and autonomic neuropathy.